Founded 2006


Unlock datapoints

Portfolio analytics



News & Media

Add fund to favorites
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 131
Average round size
The average size of a deal this fund participated in
Portfolio companies 79
Rounds per year 8.73
Lead investments 35
Follow on index
How often the fund supports its portfolio startups at next rounds
Exits 17
Key employees 3
Stages of investment
Early Stage Venture

Areas of investment

  • Software
  • Health Care
  • Medical Device
  • Biotechnology
  • Information Technology

CincyTech appeared to be the VC, which was created in 2006. The venture was found in North America in United States. The leading representative office of defined VC is situated in the Cincinnati.

The top amount of exits for fund were in 2018. The important activity for fund was in 2011. Despite it in 2019 the fund had an activity. When the investment is from CincyTech the average startup value is 5-10 millions dollars. Deals in the range of 1 - 5 millions dollars are the general things for fund. This CincyTech works on 18 percentage points less the average amount of lead investments comparing to the other organizations. The fund is constantly included in 2-6 investment rounds annually. The real fund results show that this VC is 9 percentage points more often commits exit comparing to other companies.

For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no specific favorite in a number of founders of portfolio startups. If startup sums 4 or 5+ of the founder, the chance for it to be financed is low. Among the most successful fund investment fields, there are Biotechnology, Enterprise Software. Among the various public portfolio startups of the fund, we may underline Enable Injections, SoMoLend, WorkFlex Solutions Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.

The usual cause for the fund is to invest in rounds with 3 partakers. Despite the CincyTech, startups are often financed by Queen City Angels, North Coast Angel Fund, Cincinnati Childrenu2019s. The meaningful sponsors for the fund in investment in the same round are Cincinnati Childrenu2019s, The Brandery, North Coast Angel Fund. In the next rounds fund is usually obtained by Queen City Angels, The Brandery, Cincinnati Childrenu2019s.

Besides them, we counted 3 critical employees of this fund in our database.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of CincyTech:
Typical Co-investors
CincyTech is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after CincyTech:

Notable deals

CompanyIndustryRoundRound SizeDateInvestorsLocation

Eikonoklastes Therapeutics

Life Science
$3M06 May 2021 United States, Cincinnati

$500K27 May 2020 United States, Cincinnati

Kurome Therapeutics

Health Care
29 Apr 2020 United States, Cincinnati


Artificial Intelligence
Emergency Medicine
Health Diagnostics
Machine Learning
Medical Device
$9M21 Apr 2020 United States, " United States"}

ReadySet Surgical

Cloud Data Services
Health Care
Medical Device
Supply Chain Management
$5M18 Mar 2020 United States, Cincinnati


Human Resources
Staffing Agency
16 Mar 2020 United States, Cleveland

Eikonoklastes Therapeutics

Life Science
$2M04 Mar 2020 United States, Cincinnati


Health Care
$1M20 Dec 2019 United States, Columbus


13 Dec 2019 United States, Arlington
Eikonoklastes Closes Series A Funding

– Eikonoklastes Therapeutics from Cincinnati, Ohio develops immunotherapies to treat a broad range of cancers beginning with Triple Negative Breast Cancer (TNBC), a lethal form of breast cancer that comprises 15% of all breast cancers.
– The company raised an undisclosed amount in Series A funding.
– The round was led by CincyTech with participation from New York-based Elk Capital Ventures, Jobs Ohio, Rev1, and other undisclosed investors.
– The new investment will be used to conduct Investigational New Drug (IND) enabling studies for Eikonoklastes Therapeutics’ L-ICON3 immune conjugate platform.

Kurome Therapeutics Closes $15 Million Series A Financing to Develop Targeted Kinase Inhibitors for Treatment of Hematopoietic Cancers

– Kurome Therapeutics announced the closing of a $15m Series A financing.
– The round was co-led by Medicxi and Affinity Asset Advisors with participation from founding investor CincyTech, and other existing seed investors.
– The funding will support the pre-clinical advancement of dual IRAK1/4 and panFLT3 inhibitors to target cancer cells that evade the effects of both targeted therapy and chemotherapy drugs via adaptive resistance mechanisms, having co-opted IRAK1/4-mediated immune signaling pathways to survive.
– The biology being currently investigated was discovered by Daniel Starczynowski, PhD, who is Principal investigator and Co-Leader, Hematologic Malignancies Program at Cincinnati Children’s Cancer and Blood Diseases Institute, and a leading expert in IRAK 1/4 signaling pathways in cancer.


  • No reviews are submitted yet.
Related media
Top 20 investors in North America that took part in the most Early funding rounds in Healthcare industry over the recent years
If you have found a spelling error or the data isn’t actual, please, notify us by selecting that text and pressing Ctrl+Enter. Read more
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent CincyTech?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: